SAB Biotherapeutics | 8-K: Current report
Apr 15 17:20 ET
SAB Biotherapeutics | 10-K: Annual report
Mar 29 13:23 ET
SAB Biotherapeutics | 8-K: Current report
Mar 29 09:37 ET
SAB Biotherapeutics | 8-K: Current report
Mar 8 16:31 ET
SAB Biotherapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 23 22:18 ET
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bausch Christoph Lawrence
Feb 23 22:16 ET
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kropotova Alexandra
Feb 23 17:06 ET
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Eddie Joe
Feb 23 17:05 ET
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer King Michael
Feb 23 16:57 ET
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reich Samuel J
Feb 23 16:46 ET
SAB Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(3.5%),Commodore Capital Master LP(3.5%)
Feb 14 18:07 ET
SAB Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-RTW Investments, LP(9.99%),Roderick Wong, M.D.(9.99%)
Feb 14 07:06 ET
SAB Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Radcliffe Capital Management, L.P.(0.00%),RGC Management Company, LLC(0.00%), etc.
Feb 14 06:32 ET
SAB Biotherapeutics | 8-K: Current report
Feb 2 07:55 ET
SAB Biotherapeutics | 8-K: Current report
Jan 26 16:22 ET
SAB Biotherapeutics | 424B5: Prospectus
Jan 26 16:05 ET
SAB Biotherapeutics | 8-K: Current report
Jan 25 17:08 ET
SAB Biotherapeutics | 8-K: Current report
Jan 19 00:00 ET
SAB Biotherapeutics | 8-K: Current report
Jan 3 00:00 ET
SAB Biotherapeutics | DEF 14A: Definitive information statements
Dec 18, 2023 09:34 ET
No Data
No Data